Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 4/2020

01-04-2020 | Radiotherapy | Letter to the Editor

The challenge of prognostication in palliative radiotherapy: the way forward is shared decision-making

Authors: Romina Rossi, Emanuela Scarpi, Monia Dall’Agata, Luca Tontini, Martina Pieri, Simona Micheletti, Antonino Romeo, Marianna Ricci, Maria Caterina Pallotti, Marco Maltoni

Published in: Supportive Care in Cancer | Issue 4/2020

Login to get access

Excerpt

We were very interested to read the useful update by Hui et al. on the challenging issue of prognostication.1 We fully agree on the need to improve the science and art of prognostication. The literature confirms that the increasing tendency to treat advanced cancer patients up until the very end of life, referring them to Palliative Care (PC) services when it is all but too late, has been identified as an index of poor Quality of Care (QoC).1 We wanted to reiterate the importance of the topic broached by Hui et al. and to focus attention on the somewhat controversial setting of palliative radiotherapy (PRT). …
Literature
1.
Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S (2003) Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 21:1133–1138CrossRef
2.
Gripp S, Mjartan S, Boelke E, Willers R (2010) Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth? Cancer 116:3251–3256CrossRef
3.
Lutz ST, Jones J, Chow E (2014) Role of radiation therapy in palliative care of patient with cancer. J Clin Oncol 32:2913–2919CrossRef
4.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742CrossRef
5.
Maltoni M, Scarpi E, Dall’Agata M, Schiavon S, Biasini C, Codecà C et al (2016) Systematic versus on-demand early palliative care: a randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. Eur J Cancer 69:110–118CrossRef
6.
Chow E, Abdolell M, Panzarella T, Harris K, Bezjak A, Warde P, Tannock I (2009) Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys 73:280–287CrossRef
7.
Krishnan MS, Epstein-Peterson Z, Chen YH, Tseng YD, Wright AA, Temel JS, Catalano P, Balboni TA (2014) Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: the TEACHH model. Cancer 120:134–141CrossRef
8.
Park KR, Lee CG, Tseng YD, Liao JJ, Reddy S, Bruera E, Yennurajalingam S (2017) Palliative radiation therapy in the last 30 days of life: a systematic review. Radiother Oncol 125:193–199CrossRef
9.
Maltoni M, Nanni O, Pirovano M, Scarpi E, Indelli M, Martini C et al (1999) Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manag 17:240–247CrossRef
10.
Hui D, Paiva CE, Del Fabbro EG (2019) Prognostication in advanced cancer: update and directions for future research. Support Care Cancer 27:1973–1984CrossRef
Metadata
Title
The challenge of prognostication in palliative radiotherapy: the way forward is shared decision-making
Authors
Romina Rossi
Emanuela Scarpi
Monia Dall’Agata
Luca Tontini
Martina Pieri
Simona Micheletti
Antonino Romeo
Marianna Ricci
Maria Caterina Pallotti
Marco Maltoni
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Keyword
Radiotherapy
Published in
Supportive Care in Cancer / Issue 4/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05157-6

Other articles of this Issue 4/2020

Supportive Care in Cancer 4/2020 Go to the issue

Commentary

Cancer survivors’ challenges with ostomy appliances and self-management: a qualitative analysis

Original Article

Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study

Original Article

Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)

Original Article

Healthcare provider utility ratings of a psychosocial screening summary: from diagnosis to 6 months

Letter to the Editor

Olanzapine: Sancho Panza for clinicians who care for patients with advanced cancer

Original Article

Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits